— Know what they know.
Not Investment Advice

6160.HK

BeOne Medicines AG
1W: -4.4% 1M: -23.3% 3M: -15.3% YTD: -21.3% 1Y: +22.9% 3Y: +0.7% 5Y: +11.6%
HK$164.00 ($20.98)
-3.30 (-1.97%)
 
HKSE · Healthcare · Biotechnology · HK$251.3B
Smart Money Score
Watch 25
Insider
Congress
ETF Holdings
Key Statistics
Market CapHK$251.3B ($32.1B)
52W Range115.8-229.4
Volume3,131,066
Avg Volume3,518,942
Beta0.52
Dividend
Analyst Ratings
9 Buy 3 Hold 1 Sell
Consensus Buy
Company Info
CEOJohn V. Oyler
Employees11,000
SectorHealthcare
IndustryBiotechnology
IPO Date2018-08-08
Aeschengraben 27
Basel, MA 4051
CH
41 61 685 19 00
About BeOne Medicines AG

BeiGene Ltd. is a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms